MicroRNA-24 attenuates neointimal hyperplasia in the diabetic rat carotid artery injury model by inhibiting Wnt4 signaling pathway

International Journal of Molecular Sciences

Volumn 17, Issue 6, 2016, Pages

  Yang, Jian ^a   Fan, Zhixing ^a   Yang, Jun ^a   Ding, Jiawang ^a   Yang, Chaojun ^a   Chen, Lihua ^b  

^a CHINA THREE GORGES UNIVERSITY   (China)

^b Department of General Surgery Yichang Central People s Hospital   (China)

Author keywords

Carotid artery balloon injury; Hyperglycemia; MicroRNA 24; Neointimal hyperplasia; Vascular restenosis; Vascular smooth muscle cells

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLINE; DISHEVELLED 1; MICRORNA 24; PROTEIN P21; STREPTOZOCIN; WNT4 PROTEIN; MICRORNA; MIRN24 MICRORNA, RAT; WNT4 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; GENETIC TRANSFECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RESTENOSIS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ADENOVIRIDAE; ADMINISTRATION AND DOSAGE; ANIMAL; CAROTID ARTERY INJURIES; CELL CULTURE; COMPLICATION; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE THERAPY; GENE VECTOR; GENETICS; HYPERPLASIA; NEOINTIMA; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; ANIMALS; CAROTID ARTERY INJURIES; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GENETIC THERAPY; GENETIC VECTORS; HYPERPLASIA; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STREPTOZOCIN; WNT4 PROTEIN;

EID: 85015354153     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17060765     Document Type: Article

References (35)

1. Gomes, M.B. Glitazones and the metabolic syndrome: Mechanism of action, pathophysiology and therapeutic indications. Arq. Bras. Endocrinol. Metabol. 2006, 50, 271–280. [CrossRef] [PubMed]
2. Fan, Z.; Yang, C.; Yang, J. A hypothesis: Glucagon-like peptide-1 may play a protective role in diabetic cardiomyopathy. Int. J. Cardiol. 2015, 197, 294–295. [CrossRef] [PubMed]
3. Xu, Y.; Wang, L.; He, J.; Bi, Y.; Li, M.; Wang, T. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310, 948–959. [CrossRef] [PubMed]
4. Lastra, G.; Manrique, C. Perivascular adipose tissue, inflammation and insulin resistance: Link to vascular dysfunction and cardiovascular disease. Horm. Mol. Biol. Clin. Investig. 2015, 22, 19–26. [CrossRef] [PubMed]
5. Yang, J.; Jiang, H.; Chen, S.S.; Chen, J.; Li, W.Q.; Xu, S.K. Lentivirus-mediated RNAi targeting CREB binding protein attenuatesneointimal formation and promotes re-endothelialization in balloon injured rat carotid artery. Cell. Physiol. Biochem. 2010, 26, 441–448. [CrossRef] [PubMed]
6. Suzuki, J.; Tezuka, D.; Morishita, R.; Isobe, M. An initial case of suppressed restenosis with nuclear factor-kB decoy transfection after percutaneous coronary intervention. J. Genet. Med. 2009, 11, 89–91.
7. Hao, H.; Gabbiani, G.; Bochaton-Piallat, M.L. Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1510–1520. [CrossRef] [PubMed]
8. Zhang, J.; Chen, J.; Xu, C.; Yang, J.; Guo, Q.; Hu, Q. Resveratrol inhibits phenotypic switching of neointimal vascular smooth muscle cells after balloon injury through blockade of Notch pathway. J. Cardiovasc. Pharmacol. 2014, 63, 233–239. [CrossRef] [PubMed]
9. Benter, I.F.; Sarkhou, F.; Al-Khaldi, A.T.; Chandrasekhar, B.; Attur, S.; Dhaunsi, G.S. The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes. J. Drug Target. 2015, 23, 506–518. [CrossRef] [PubMed]
10. Rawal, S.; Manning, P.; Katare, R. Cardiovascular microRNAs: As modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc. Diabetol. 2014, 13, 44. [CrossRef] [PubMed]
11. Fan, Z.X.; Yang, J. Microribonucleic acids and vascular restenosis. Saudi. Med. J. 2014, 35, 796–801. [PubMed]
12. Ji, R.; Cheng, Y.; Yue, J.; Yang, J.; Liu, X.; Chen, H. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ. Res. 2007, 100, 1579–1588. [CrossRef] [PubMed]
13. Marchand, A.; Atassi, F.; Gaaya, A.; Leprince, P.; Le Feuvre, C.; Soubrier, F. The Wnt/β-catenin pathway is activated during advanced arterial aging in humans. Aging Cell. 2011, 10, 220–232. [CrossRef] [PubMed]
14. Tsaousi, A.; Williams, H.; Lyon, C.A.; Taylor, V.; Swain, A.; George, S.J. Wnt/β-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ. Res. 2011, 108, 427–436. [CrossRef] [PubMed]
15. Quasnichka, H.; Slater, S.C.; Beeching, C.A.; Boehm, M.; Sala-Newby, G.B.; George, S.J. Regulation of smooth muscle cell proliferation by β-catenin/T-cell factor signaling involves modulation of Cyclin D1 and p21 expression. Circ. Res. 2006, 99, 1329–1337. [CrossRef] [PubMed]
16. Hua, J.Y.; He, Y.Z.; Xu, Y.; Jiang, X.H.; Ye, W.; Pan, Z.M. Emodin prevents intima thickness via Wnt4/Dvl-1/β-catenin signalingpathway mediated by miR-126 in balloon-injured carotid artery rats. Exp. Mol. Med. 2015, 47, e170. [CrossRef] [PubMed]
17. Gao, C.; Chen, Y.G. Dishevelled: The hub of wnt signaling. Cell Signal. 2010, 22, 717–727. [CrossRef] [PubMed]
18. Hua, J.; Xu, Y.; He, Y.; Jiang, X.; Ye, W.; Pan, Z. Wnt/β-catenin signaling pathway modulates balloon-injured carotid arteryrestenosis via disheveled-1. Int. J. Clin. Exp. Pathol. 2014, 7, 8421–8431. [PubMed]
19. Lewis, B.P.; Shih, I.H.; Jones-Rhoades, M.W.; Bartel, D.P.; Burge, C.B. Prediction of Mammalian MicroRNA Targets. Cell 2003, 115, 787–798. [CrossRef]
20. Patti, G.; Nusca, A.; di Sciascio, G. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus. Am. J. Cardiol. 2008, 102, 1328–1334. [CrossRef] [PubMed]
21. Salvi, A.; Abeni, E.; Portolani, N.; Barlati, S.; de Petro, G. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC. Int. J. Oncol. 2013, 42, 391–402. [PubMed]
22. Chan, M.C.; Hilyard, A.C.; Wu, C.; Davis, B.N.; Hill, N.S.; Lal, A. Molecular basis for antagonism between PDGF and the TGF β family of signalling pathways by control of miR-24 expression. EMBO J. 2010, 29, 559–573. [CrossRef] [PubMed]
23. Wang, X.; Xiao, Y.; Mou, Y.; Zhao, Y.; Blankesteijn, W.M.; Hall, J.L. A role for the β-catenin/T-cell factor signaling cascade in vascular remodeling. Circ. Res. 2002, 90, 340–347. [CrossRef] [PubMed]
24. Grandy, D.; Han, J.; Zhang, X.; Rao, S.; Akunuru, S.; Li, H. Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled. J. Biol. Chem. 2009, 284, 16256–16263. [CrossRef] [PubMed]
25. Wallingford, J.B.; Habas, R. The developmental biology of dishevelled: An enigmatic protein governing cell fate and cell polarity. Development 2005, 132, 4421–4436. [CrossRef] [PubMed]
26. Vlad-Fiegen, A.; Langerak, A.; Eberth, S.; Müller, O. The Wnt pathway destabilizes adherens junctions and promotes cell migration via β-catenin and its target gene cyclin D 1. FEBS Open Bio 2012, 2, 26–31. [CrossRef] [PubMed]
27. Kamei, J.; Toyofuku, T.; Hori, M. Negative regulation of p21 by β-catenin/TCF signaling: A novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochem. Biophys. Res. Commun. 2003, 312, 380–387. [CrossRef] [PubMed]
28. Bond, M.; Sala-Newby, G.B.; Wu, Y.J.; Newby, A.C. Biphasic effect of p21Cip1 on smooth muscle cell proliferation: Role of PI 3-kinase and Skp2-mediated degradation. Cardiovasc. Res. 2006, 69, 198–206. [CrossRef] [PubMed]
29. Yang, J.; Fan, Z.; Yang, C.; Yang, J. MicroRNA-facilitated gene delivery:A potential therapeutic approach for vascularrestenosis without influencing endothelial function. Int. J. Cardiol. 2015, 201, 351–352. [CrossRef] [PubMed]
30. Santulli, G.; Wronska, A.; Uryu, K.; Diacovo, T.G.; Gao, M.; Marx, S.O. A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J. Clin. Investig. 2014, 124, 4102–4114. [CrossRef] [PubMed]
31. Lyon, A.R.; Sato, M.; Hajjar, R.J.; Samulski, R.J.; Harding, S.E. Gene therapy: Targeting the myocardium. Heart 2008, 94, 89–99. [CrossRef] [PubMed]
32. Mason, D.; Chen, Y.Z.; Krishnan, H.V.; Sant, S. Cardiac gene therapy: Recent advances and future directions. J. Control. Release 2015, 215, 101–111. [CrossRef] [PubMed]
33. Yu, H.T.; Zhen, J.; Pang, B.; Gu, J.N.; Wu, S.S. Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats. J. Zhejiang Univ. Sci. B 2015, 16, 344–354. [CrossRef] [PubMed]
34. Yang, B.; Yang, J.; Bai, J.; Pu, P.; Liu, J.; Wang, F. Suv39h1 protects from myocardial ischemia-reperfusion injury in diabetic rats. Cell. Physiol. Biochem. 2014, 33, 1176–1185. [CrossRef] [PubMed]
35. Yang, J.; Chen, L.; Yang, J.; Ding, J.; Li, S.; Wu, H. MicroRNA-22 targeting CBP protects against myocardial ischemia-reperfusion injury through anti-apoptosis in rats. Mol. Biol. Rep. 2014, 41, 555–561. [CrossRef] [PubMed]